Sign inGet started

Rajah Vignesh

Insider CIK 1815042 · YMAB SVP and CMO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
YMAB Y-mAbs Therapeutics, Inc. S Sale2024-03-052024-03-071,711$16.53 $28.3K33,889SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2024-01-182024-01-2235,700— $035,700SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2024-01-182024-01-2217,800— $035,600SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2023-01-262023-01-3032,000— $032,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2023-01-172023-01-1935,700— $035,700SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2023-01-172023-01-1917,800— $017,800SEC↗
YMAB Y-mAbs Therapeutics, Inc. P Buy2022-11-152022-11-161,195$4.92 $5.9K4,266SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2022-04-262022-04-2820,000— $020,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2021-12-142021-12-1632,000— $032,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. P Buy2021-08-122021-08-131,374$29.95 $41.2K3,071SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2020-12-152020-12-1620,000— $020,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. P Buy2020-12-022020-12-04233$51.03 $11.9K1,697SEC↗
YMAB Y-mAbs Therapeutics, Inc. P Buy2020-11-172020-12-041,464$45.74 $67.0K1,464SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2020-06-232020-06-2440,000— $040,000SEC↗